2024-512311-41-00CompletedPhase 1
Randomised, bioequivalence clinical trial of rasagiline 1 mg capsules vs rasagiline 1 mg tablets, after a single oral dose administration to healthy volunteers under fasting conditions in crossover replicated design.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 13 Jun 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 2 Mar 2024
- Start date
- 3 Jun 2024
- Lead sponsor
- Laboratorios Alter S.A.
- EU CT number
- 2024-512311-41-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 48
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario de la Princesa | Madrid | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.